Harold Alfond Foundation charitable gift to help improve cancer care in the state of Maine

June 08, 2016

A charitable contribution of $8,410,000 from the Harold Alfond® Foundation will support The Jackson Laboratory's (JAX) efforts to enhance cancer diagnostics and treatment in Maine.

"The Jackson Laboratory is uniquely positioned to apply more than 86 years of expertise in cancer research to the improvement of cancer care in our state," says Gregory W. Powell, Chairman of the Foundation's Board of Trustees. "We are delighted to partner with the Laboratory to improve the health of the people in Maine."

"Most American cancer patients get their care at community hospitals, in rural or suburban settings, and this is especially true in Maine," says Edison Liu, M.D., president and CEO of The Jackson Laboratory and director of The Jackson Laboratory Cancer Center. "Thanks to the vision of the Harold Alfond Foundation, and, working in collaboration with MaineGeneral Medical Center and its Harold Alfond Center for Cancer Care, JAX will work to ensure that all Maine cancer patients and their physicians have access to precision cancer care using the latest advances in genetic technologies, allowing them to determine the best treatment for a particular cancer."
Founded in 1950, the Harold Alfond® Foundation furthers the philanthropic legacy of Harold Alfond, the founder of Dexter Shoe Company and a longtime supporter of Maine communities in which he and his family worked and resided. Consistent with Harold Alfond's own giving pattern and philanthropic principles, the Foundation favors education, healthcare, youth development and other selected charitable causes.

Founded in 1929 as one of the world's first cancer genetics research institutions, today JAX has a National Cancer Institute-designated Cancer Center, with cancer research faculty at its Bar Harbor, Maine, headquarters campus and The Jackson Laboratory for Genomic Medicine in Farmington, Conn. JAX has recently expanded its efforts to include translational and clinical genomics research and advanced genomics diagnostics tools for oncologists and their patients.

Jackson Laboratory

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.